Chemotherapeutic Potential of Monensin as an Anti-microbial Agent
Vinoth Rajendran1, Hema Saranya Ilamathi1,2,3, Suparna Dutt4
1Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, New Delhi 110021, India.
Abstract:
Monensin is a lipid-soluble naturally occurring bioactive ionophore produced by Streptomyces spp. Its antimicrobial activity is mediated by its ability to exchange Na+ and K+ ions across the cell membrane thereby disrupting ionic gradients and altering cellular physiology. It is approved by Food and Drug Administration as a veterinary antibiotic to treat coccidiosis. Besides veterinary applications, monensin exhibits a broad spectrum activity against opportunistic pathogens of humans such as bacteria, virus, fungi and parasites in both drug sensitive and resistant strains. This ionophore can selectively kill pathogens with negligible toxic effect on mammalian cells. In this review, we discuss the therapeutic potential of monensin as a new broad-spectrum anti-microbial agent that warrants further studies for clinical use.
Insights
Monensin, an ionophore antibiotic, shows broad-spectrum antimicrobial activity against human pathogens. Further research is recommended for its clinical use as a safe and effective therapeutic agent.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Monensin is a naturally occurring ionophore produced by Streptomyces spp.
- It functions by disrupting ionic gradients across cell membranes.
- Currently approved as a veterinary antibiotic for coccidiosis.
Purpose of the Study:
- To review the therapeutic potential of monensin.
- To explore its broad-spectrum antimicrobial activity against human pathogens.
- To assess its efficacy against drug-sensitive and resistant strains.
Main Methods:
- Literature review of monensin's antimicrobial properties.
- Analysis of its mechanism of action.
- Evaluation of its selective toxicity.
Main Results:
- Monensin exhibits broad-spectrum activity against bacteria, viruses, fungi, and parasites.
- It is effective against both drug-sensitive and drug-resistant strains.
- Monensin demonstrates selective toxicity, with negligible effects on mammalian cells.
Conclusions:
- Monensin possesses significant therapeutic potential as a novel antimicrobial agent.
- Its broad-spectrum activity and safety profile warrant further clinical investigation.
- Monensin could be a valuable addition to the antimicrobial armamentarium.
Related Concept Videos
Chemical Agents for Microbial Control
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Microbial Morphologies
Microbial Fermentation
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Microbial Nutrition


